Literature DB >> 29070655

Evaluation of a Modified Carbapenem Inactivation Method for Detection of Carbapenemases in Pseudomonas aeruginosa.

Luiz F Lisboa1, LeeAnn Turnbull2, David A Boyd3, Michael R Mulvey3, Tanis C Dingle4,5.   

Abstract

Entities:  

Keywords:  Pseudomonas aeruginosa; carbapenem inactivation method; carbapenemase

Mesh：

Substances：

Year:  2017        PMID： 29070655      PMCID： PMC5744227          DOI： 10.1128/JCM.01234-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  13 in total

1.  Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Antonios Markogiannakis; Nicholas Spanakis; Antonios N Maniatis; Athanassios Tsakris
Journal:  J Med Microbiol       Date:  2007-01       Impact factor: 2.472

2.  Detection of carbapenemase-producers: Evaluating the performance of the carbapenem inactivation method and Carba NP test versus multiplex PCR.

Authors:  Lamiaa A Madkour; May S Soliman; Dina M Hassan; Noha S Soliman; Yasmin A ElMahdy
Journal:  J Glob Antimicrob Resist       Date:  2017-03-09       Impact factor: 4.035

3.  Evaluation of Genotypic and Phenotypic Methods to Detect Carbapenemase Production in Gram-Negative Bacilli.

Authors:  Allison R McMullen; Melanie L Yarbrough; Meghan A Wallace; Angela Shupe; Carey-Ann D Burnham
Journal:  Clin Chem       Date:  2017-01-10       Impact factor: 8.327

4.  Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.

Authors:  Virginia M Pierce; Patricia J Simner; David R Lonsway; Darcie E Roe-Carpenter; J Kristie Johnson; William B Brasso; April M Bobenchik; Zabrina C Lockett; Angella Charnot-Katsikas; Mary Jane Ferraro; Richard B Thomson; Stephen G Jenkins; Brandi M Limbago; Sanchita Das
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

5.  Evaluation of the Carbapenem Inactivation Method for Detection of Carbapenemase-Producing Gram-Negative Bacteria in Comparison with the RAPIDEC CARBA NP.

Authors:  Elif Aktaş; Gülşah Malkoçoğlu; Barış Otlu; Ayşegül Çopur Çiçek; Canan Külah; Füsun Cömert; Cemal Sandallı; Nafia Canan Gürsoy; Duygu Erdemir; Mehmet Emin Bulut
Journal:  Microb Drug Resist       Date:  2016-08-30       Impact factor: 3.431

6.  Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.

Authors:  Mohammad Taghi Akhi; Younes Khalili; Reza Ghotaslou; Hossein Samadi Kafil; Saber Yousefi; Behroz Nagili; Hamid Reza Goli
Journal:  J Chemother       Date:  2016-07-22       Impact factor: 1.714

7.  Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases.

Authors:  Hilary Frase; Qicun Shi; Sebastian A Testero; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

8.  Integron mobilization unit as a source of mobility of antibiotic resistance genes.

Authors:  Laurent Poirel; Amélie Carrër; Johann D Pitout; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.

Authors:  Kim van der Zwaluw; Angela de Haan; Gerlinde N Pluister; Hester J Bootsma; Albert J de Neeling; Leo M Schouls
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Authors:  Laura F Mataseje; Kahina Abdesselam; Julie Vachon; Robyn Mitchel; Elizabeth Bryce; Diane Roscoe; David A Boyd; Joanne Embree; Kevin Katz; Pamela Kibsey; Andrew E Simor; Geoffrey Taylor; Nathalie Turgeon; Joanne Langley; Denise Gravel; Kanchana Amaratunga; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191
View more
  5 in total

1.  Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa Isolates.

Authors:  Christian M Gill; Tomefa E Asempa; Isabella A Tickler; Caitlin Dela Cruz; Fred C Tenover; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

2.  Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Christian M Gill; Maxwell J Lasko; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

3.  Practical Agar-Based Disk Diffusion Tests Using Sulfamoyl Heteroarylcarboxylic Acids for Identification of Subclass B1 Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Chihiro Norizuki; Jun-Ichi Wachino; Wanchun Jin; Kouji Kimura; Kumiko Kawamura; Noriyuki Nagano; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2021-07-14       Impact factor: 5.948

4.  EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations.

Authors:  Maxwell J Lasko; Christian M Gill; Tomefa E Asempa; David P Nicolau
Journal:  BMC Microbiol       Date:  2020-07-20       Impact factor: 3.605

5.  The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Christian M Gill; Elif Aktaþ; Wadha Alfouzan; Lori Bourassa; Adrian Brink; Carey-Ann D Burnham; Rafael Canton; Yehuda Carmeli; Marco Falcone; Carlos Kiffer; Anna Marchese; Octavio Martinez; Spyros Pournaras; Michael Satlin; Harald Seifert; Abrar K Thabit; Kenneth S Thomson; Maria Virginia Villegas; David P Nicolau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-22       Impact factor: 3.267
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.